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Abstract
Background
Campylobacter is a major foodborne pathogen and alternative antimicrobials are needed to prevent or
decrease Campylobacter contamination in foods or food producing animals. The objectives of this study are to
define the anti-Campylobacter activities of natural phenolic compounds of plant origin and to determine the
roles of bacterial drug efflux systems in the resistance to these natural phenolics in Campylobacter jejuni.
Methodology/Principal Findings
Anti-Campylobacter activities were evaluated by an MIC assay using microdilution coupled with ATP
measurement. Mutants of the cmeB and cmeF efflux genes and the cmeR transcriptional repressor gene were
compared with the wild-type strain for their susceptibilities to phenolics in the absence and presence of efflux-
pump inhibitors (EPIs). The phenolic compounds produced significant, but variable activities against both
antibiotic-susceptible and antibiotic resistant Campylobacter. The highest anti-Campylobacter activity was
seen with carnosic and rosmarinic acids in their pure forms or in enriched plant extracts. Inactivation of cmeB
rendered C. jejuni significantly more susceptible to the phenolic compounds, while mutation of cmeF or
cmeR only produced a moderate effect on the MICs. Consistent with the results from the efflux pump
mutants, EPIs, especially phenylalanine-arginine β-naphthylamide and NMP, significantly reduced the MICs
of the tested phenolic compounds. Further reduction of MICs by the EPIs was also observed in the cmeB and
cmeF mutants, suggesting that other efflux systems are also involved in Campylobacter resistance to phenolic
compounds.
Conclusion/Significance
Natural phenolic compounds of plant origin have good anti-Campylobacter activities and can be further
developed for potential use in controlling Campylobacter. The drug efflux systems in Campylobacter
contribute significantly to its resistance to the phenolics and EPIs potentiate the anti-Campylobacter activities
of plant phenolic compounds.
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anti-Campylobacter activities of natural phenolic compounds of plant origin and to determine the roles of bacterial drug
efflux systems in the resistance to these natural phenolics in Campylobacter jejuni.
Methodology/Principal Findings: Anti-Campylobacter activities were evaluated by an MIC assay using microdilution
coupled with ATP measurement. Mutants of the cmeB and cmeF efflux genes and the cmeR transcriptional repressor gene
were compared with the wild-type strain for their susceptibilities to phenolics in the absence and presence of efflux-pump
inhibitors (EPIs). The phenolic compounds produced significant, but variable activities against both antibiotic-susceptible
and antibiotic resistant Campylobacter. The highest anti-Campylobacter activity was seen with carnosic and rosmarinic acids
in their pure forms or in enriched plant extracts. Inactivation of cmeB rendered C. jejuni significantly more susceptible to the
phenolic compounds, while mutation of cmeF or cmeR only produced a moderate effect on the MICs. Consistent with the
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reduced the MICs of the tested phenolic compounds. Further reduction of MICs by the EPIs was also observed in the cmeB
and cmeF mutants, suggesting that other efflux systems are also involved in Campylobacter resistance to phenolic
compounds.
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Introduction
Campylobacter jejuni is the leading bacterial cause of human food-
borne enteritis in many industrialised countries. Food-borne
exposure to Campylobacter spp. is most frequent through consump-
tion of undercooked, contaminated broiler chicken meat, and
through cross-contamination with other foods during meat
preparation [1]. Additionally, Campylobacter spp. have become
increasingly resistant to antimicrobials, which thus compromises
the effectiveness of its control in the food chain as well as antibiotic
treatments [2,3].
The control of Campylobacter spp. represents a major goal for the
improvement of food safety and public health. Different types of
alternative bioactive compounds have been screened for potential
anti-Camyplobacter effects. A potential strategy for controlling
foodborne pathogens, including Campylobacter, is screening, devel-
opment and use of natural antimicrobial and resistance-modifying
agents, preferably derived from plants because of their Generally
Recognised as Safe (GRAS) status [4].
Plants are known to produce an enormous variety of the small-
molecule antibiotics that are generally classified as ‘phytoalexins’.
The structural molecular space of these phytoalexins is diverse, as
they include terpenoids, glycosteroids, flavonoids and polyphenols.
They generally have weak antibiotic activities that are several
orders of magnitudes less than those of the common antibiotics
produced by bacteria and fungi [5]. However, although such
plant-derived antibacterials are less potent, plants can fight off
infections successfully [5] and plant-based antibacterials can be
further modified to enhance efficacy.
Among others, phenolic extracts from many different plant
materials have been characterized [6–9]. As an example, rosemary
(Rosemarinus officinalis L.) is an aromatic plant that has been
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successfully exploited for commercial use as an antioxidant and
antimicrobial, and its extracts are widely used in cosmetic and
pharmacetucial products and in the food [10].
Other examples are grape skin and vine leaf extracts of Vitis
vinifera varieties [11]. These extracts are of increasing interest in
the food industry because they reduce the oxidative degradation of
lipids and can thereby improve the quality and nutritional value of
foods [12,13]. Additionally, these extracts have antimicrobial
activities. The sensitivity of bacteria to polyphenols depends on the
bacterial species and the structure of the polyphenol [14,15].
Campylobacter spp., different from other food-borne bacteria, have
unique surface structures and lack the typical stress-adaptive
responses [16,17]. In general, campylobacters are more sensitive
to different phenolics than other enteric pathogens [4,18].
Multiple mechanisms associated with antibiotic resistance have
been identified in Campylobacter spp., including target mutations,
antibiotic modification/inactivation, and drug efflux [2,19]. The
main RND (resistance-nodulation-cell division)-type efflux pump,
known as CmeABC, mediates the extrusion of structurally diverse
antimicrobials and contributes to intrinsic and acquired resistance
to various antimicrobials [20–22]. This system is encoded by a
three-gene operon and is composed of a transporter protein
(CmeB), a periplasmic membrane fusion protein (CmeA), and an
outer membrane factor (CmeC). Expression of cmeABC is regulated
by CmeR, a transcription repressor that is encoded by a gene
immediately upstream of cmeA [23,24]. CmeR binds directly to an
inverted repeat in the promoter region of cmeABC and inhibits the
transcription of this efflux operon [23,25]. In addition, C. jejuni has
another RND-type efflux system, CmeDEF, which plays a
secondary role in conferring intrinsic resistance, with CmeD,
CmeE and CmeF as an outer membrane channel protein,
periplasmic fusion protein and inner membrane transporter,
respectively. CmeDEF has different substrate-binding properties
and interacts with CmeABC in conferring antimicrobial resistance
[26].
The goal of this study is to evaluate the anti-Campylobacter
activities of various plant phenolics and assess if efflux mechanisms
are involved in the resistance of C. jejuni to these phenolics (pure
phenolic compounds and extracts of plant phenolics). First, we
analyzed the susceptibilities of C. jejuni isolates of various origins,
wild-type C. jejuni 11168 and its efflux mutants (cmeB, cmeF and
cmeR) to these phenolic compounds. Second, we used known
efflux-pump inhibitors (EPIs) to determine if the EPIs potentiate
the anti-Campylobacter activities of the natural phenolic compounds.
Our findings demonstrate the potential use of plant-based
phenolics in controlling Campylobacter and provide new insights
into the resistance mechanisms of Campylobacter to the antimicro-
bials of plant origin.
Materials and Methods
Bacterial Strains, Generation of Efflux Mutants, and
Growth Conditions
Eleven food, animal, water and human Campylobacter strains
were used in the present study. They were isolated and identified
phenotypically and by multiplex polymerase chain reaction
(mPCR), as described previously [27]. The reference human
clinical isolate of C. jejuni NCTC 11168 was provided by Sophie
Payot (French National Institute for Agricultural Research,
UR086 BioAgresseurs, Sante` e Environnement, Nouzilly, France).
Natural transformation [28] was used to generate the mutants of
cmeB, cmeF, and cmeR. In the transformation experiment, the donor
DNA was genomic DNA prepared from the corresponding mutant
strains published previously [20,23,26] and the recipient strain was
NCTC 11168. The transformants of cmeB (referred to as 11168B)
were selected on Mu¨ller Hinton (MH) agar (Oxoid, Hampsire,
UK) with 30 mg kanamycin/mL, while the cmeF (11168F) and
cmeR (11168R) transformants were selected on MH agar plates
with 4 mg chloramphenicol/mL. The mutants of cmeB, cmeF and
cmeR were confirmed by PCR using specific primers (Table 1). The
cultures were stored at 280uC in brain–heart infusion broth
(Oxoid) supplemented with 5% horse blood (Oxoid) and glycerol
(Kemika, Zagreb, Croatia). The isolates were sub-cultured on
Columbia agar (Oxoid) supplemented with 5% horse blood
(Oxoid), at 42uC in gas-tight containers under micro-aerobic
conditions (5% O2, 10% CO2, 85% N2).
Pure Phenolic Compounds and Extracts of Plant
Phenolics
The natural phenolic compounds used in the present study
included nine pure phenolic compounds and 22 extracts of plant
phenolics. The pure phenolic compounds were: (2)-epigalloca-
techin gallate (EGCG), chlorogenic acid, gallic acid, sinapinic acid,
vanillic acid, syringic acid, ferulic acid (all from Sigma-Aldrich
GmbH, Steinheim, Germany), rosmarinic acid and carnosic acid
(both from Chromadex, Santa Ana, CA, USA). The extracts of
plant phenolics used included commercially available rosemary
(Rosemarinus officinalis L) extracts with different contents of carnosic
acid (CA) and rosmarinic acid (RA): I18 (18.8% CA), V40 (40%
CA), V70 (70% CA), A40 (40% RA) (Vitiva, Markovci, Slovenia).
The other extracts were prepared from sage (Salvia officinalis),
peppermint (M. balsamea Willd), lemon balm (Melissa officinalis),
oregano (Origanum vulgare), green tea (Camellia sinensis), thyme
(Thymus mongolicus), bearberry (Arctostaphylos uva ursi), black seeds
(Nigella sativa) as well as from grapes skin and leaf extracts of Vitis
vinifera L. from different red (Lasin, Merlot, Vranac, Babic´) and white
(Rkaciteli, Zlatarica, Debit, Kujundzˇusˇa, Trnjak, Rudezˇusˇa) grape
varieties as described previously [4,11,13,29].
Briefly, plant phenolic extracts were lyophilised and then
dissolved in absolute ethanol to provide the stock solutions. They
were further diluted in the appropriate media to the working
concentrations. Two-fold serial dilutions of the pure phenolic
compounds and the herb were used at concentrations from
0.6 mg/mL to 1,250 mg/mL, as for all of the vine leaf and grape
skin extracts at concentrations from 7.8 mg/mL to 16,000 mg/mL.
PCR Confirmation of the Gene Knock-out Mutants
The genomic DNA was extracted using the PrepMan Ultra
sample preparation reagent (Applied Biosystems, Foster City,
California, USA) from pure cultures of the wild-type NCTC
11168 and its mutant strains grown in Mu¨ller Hinton broth
(Oxoid). One mL of overnight culture was centrifuged at 13,0006
g for 3 min to pellet the bacteria. The pellet was resuspended in
100 mL PrepMan Ultra sample preparation reagent, mixed for
30 s, and heated in a water-bath at 95uC for 10 min. The
suspension was again centrifuged at 13,0006 g for 3 min, and the
supernatant was removed into a fresh tube. The PCR primers used
in the present study and the expected sizes of the products are
listed in Table 1. The PCR mix and the cycling conditions varied
according to the expected sizes of the products. PCR amplifica-
tions for cmeF and cmeR were performed in a 25-mL reaction
volume containing 106 RED Taq PCR buffer, 25 mM MgCl2,
20 mM dNTP (Promega, Madison, USA), 300 nM forward
primer and 300 nM reverse primer (Table 1), 1 U/mL RED
Taq polymerase (Sigma-Aldrich GmbH, Steinheim, Germany)
and 2 mL DNA lysate. The PCR was performed in a 2400
GeneAmp thermal cycler PCR system (Perkin Elmer, Waltham,
Massachusetts, USA) at 95uC for 300 s (one cycle), 95uC for 15 s,
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50uC for 30 s, and 72uC for 45 s (35 cycles); plus 72uC for 7 min
(one cycle). PCR amplification for cmeB was performed in a 20-ml
reaction volume containing 56 Phusion High-Fidelity DNA
polymerase buffer (New England Biolabs, Herts, UK), 25 mM
MgCl2, 20 mM dNTP, 300 nM forward primer and 300 nM
reverse primer (Table 1), 1 U/mL Phusion High-Fidelity DNA
polymerase (New England Biolabs, Herts, UK) and 2 mL DNA
lysate. The cycling conditions for the PCR were at 98uC for 30 s
(one cycle); 98uC for 10 s, 50uC for 30 s, and 72uC for 60 s (30
cycles); plus 72uC for 7 min (one cycle). The PCR products were
electrophoresed on 2% agarose gels.
Antimicrobial Susceptibility Testing
The broth microdilution method was used for measuring the
MICs as described previously [4]. The MICs were defined as the
lowest concentration of an antimicrobial where no metabolic
activity is seen after 24 h, and they were determined on the basis
of the bioluminescence signal measured using a microplate reader
(Tecan, Mannedorf/Zurich, Switzerland) after adding the CellTi-
ter-Glo reagent (Promega Corporation, Madison, USA) to the
culture media [4]. All of the MIC measurements were carried out
in duplicate or triplicate. The control wells were prepared with
culture medium, with the bacterial suspension only, or alterna-
tively with the antimicrobial only, and with ethanol corresponding
to the highest concentration present in the preparations. The
ethanol controls did not show any inhibitory effects on the growth
of the strains tested (data not shown).
Efflux Pump Inhibitors
To investigate the contributions of antibiotic efflux pumps in
natural antimicrobial resistance, the wild-type and mutant strains
were tested with the phenolic compounds in the absence and
presence of EPIs. The MICs of the tested wild-type and cmeB, cmeR
and cmeF mutants were determined using the broth microdilution
method in the absence and presence of five EPIs: PAbN, NMP
(Chess, Mannheim, Germany), verapamil, reserpine and CCCP
(Sigma-Aldrich). For this purpose, Mu¨ller Hinton broth was
supplemented with 20 mg/mL PAbN, 100 mg/mL NMP, 100 mg/
mL verapamil, 100 mg/mL reserpine or 0.25 mg/mL CCCP.
Microdilution tests were also performed in preliminary indepen-
dent experiments to determine the MICs of the EPIs used for all of
the strains tested. The selected concentrations of the EPIs had no
inhibitory effects on bacterial growth for any of the strains tested.
Statistical Analysis
The MICs shown in Table 2 were compared using the
independent-samples T-tests to define the significance of the
differences in resistances between C. jejuni and C. coli, between
erythromycin-susceptible and erythromycin-resistant isolates, and
between pure phenolic compounds and phenolic extracts. For the
data in Tables 3, 4, and 5, the fold differences in MICs were log2
transformed and were used for statistical analyses. One sample
t test was used to test the null hypothesis that there was no
difference [log2(fold difference) = 0] in the MICs between the wild
type strain and a mutant strain (Table 3) or between EPI-treated
and non-treated in a given strain (Tables 4 and 5). Results were
considered significant when P#0.05. Statistical analyses were
performed with IBM SPSS statistic software, v18.0.
Results and Discussion
Anti-Campylobacter Activity of the Different Natural
Phenolic Compounds
In previous studies of the antimicrobial activities of phenolic
extracts from different plant sources, Klancˇnik et al. [4,29]
reported that campylobacters were more sensitive to different
phenolic compounds or extracts than other examined enteric
organisms, despite the fact that Campylobacter is a gram-negative
bacterium. In the present study, we conducted a comprehensive
evaluation of the anti-Campylobacter activities of the pure phenolic
compounds and different plant extracts using Campylobacter isolates
from different sources, various mutant constructs and EPIs.
The antimicrobial activities against different Campylobacter
strains are shown in Table 2, which showed variable anti-
Campylobacter activities of the selected natural phenolic acids and
plant extracts. The tested C. coli isolates (137, 140, 171, FC8,
FC10, VC7114, VC10076) were previously shown to be resistant
to erythromycin, ciprofloxacin and tetracycline [30]. Statistical
analysis indicated no significant differences between erythromycin-
susceptible and erythromycin-resistant isolates in their susceptibil-
ity to most of the examined pure phenolics and plant extracts. The
statistical analysis also showed that most of the tested compounds
had similar activities against both C. coli and C. jejuni isolates
(Table 2). These results indicate that the tested phenolics and plant
extracts are generally effective against both antibiotic-resistant and
antibiotic-susceptible Campylobacter and suggest that the action
mode of phenolic compounds is different from the antibiotics.
The MIC of NCTC 11168 and its mutants strains are shown in
Table 3. Among the 9 pure phenolic compounds examined, the
most effective ones were EGCG and carnosic acid, with a MIC of
78 mg/mL and 19.5 mg/mL, respectively, for wild-type 11168
(Table 3). Rosmarinic acid showed a good activity, too
(MIC = 156 mg/mL). For the plant extracts, good antimicrobial
activities were observed with rosemary extracts (V40, V70, A40),
containing rosmarinic and carnosic acids as the major compo-
nents. Additionally, phenolic extracts from peppermint and green
tea showed activities similar to those detected for pure rosmarinic
acid and the rosemary extract A40 (where rosmarinic acid is the
main component). The other herb extracts (lemon balm, oregano,
Table 1. PCR primer pairs used in the present study.
Target gene Primer pair n-mer Sequence (59–39) Reference or source
cmeB cmeB BF1 24 GCT GGA TCC ATA GGT CTT ACA AAT Lin et al., 2002 [20]
cmeB CR 27 TTT TTA AAG CTT TAA GGT AAT TTT CTT Lin et al., 2002 [20]
cmeF cmeF FF1 24 AAG TAC AAC TCT CAT TGC TTG CAT Akiba et al., 2006 [26]
cmeF FR1 20 TGG CTA TTG CCA TAG GAG AA Akiba et al., 2006 [26]
cmeR cmeR F 24 TAG AAA AGT ATA TTT GTA TAC CCT Lin et al., 2005a [23]
cmeR GSR4 21 GAA ATTT TTG GCT AAT TATAT Lin et al., 2005a [23]
doi:10.1371/journal.pone.0051800.t001
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thyme, bearberry, black seeds) and some vine-leaf extracts (Lasin,
Merlot, Vranac, Debit, Zlatarica) showed moderate anti-Campylobacter
activities, with MICs from 313 mg/mL to 1,250 mg/mL. The
other vine-leaf extracts (Kujundzˇusˇa, Rkaciteli, Trnjak, Rudezˇusˇa, and
Babic´) were less effective, with MICs of 1,000 mg/mL to 8,000 mg/
mL (Table 3).
Role of CmeABC and CmeDEF in the Resistance to the
Natural Phenolic Compounds
We used gene knockout mutants to determine the specific roles
of CmeABC and CmeDEF efflux pumps in the resistance to the
natural phenolic compounds. The cmeB mutant (11168B), cmeF
mutant (11168F) and cmeR mutant (11168R) were compared with
the wild-type strain (11168) using the MIC assay. As shown in
Table 3, the gene mutations had varied impacts on the
susceptibility to the phenolic compounds and extracts. The
insertional inactivation of cmeB resulted in the most obvious,
Table 3. Susceptibilities of C. jejuni 11168 and its efflux mutants to pure phenolic compounds and phenolic extracts of plant
origin.
Antimicrobial 11168 11168B* 11168F 11168R
MIC (mg/mL) MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff.
Phenolic compounds
EGCG 78 78 1 78 1 313 0.25
Rosmarinic 156 1.2 128 313 0.5 313 0.5
Carnosic 19.5 19.5 1 39 0.5 78 0.25
Chlorogenic 313 4.9 64 313 1 313 1
Gallic 313 4.9 64 78 4 78 4
Sinapinic 313 78 4 156 2 156 2
Vanillic 313 39 8 313 1 156 2
Syringic 313 78 4 156 2 156 2
Ferulic 313 78 4 156 2 156 2
Rosemary extracts
I18 313 19.5 16 625 0.50 156 2
V40 78 9.8 8 156 0.50 156 0.50
V70 78 4.9 16 78 1 78 1
A40 156 2.4 64 156 1 313 0.5
Herb extracts
Sage 313 4.9 64 156 2 156 2
Peppermint 156 9.8 16 156 1 156 1
Lemon balm 625 9.8 64 156 4 313 2
Oregano 1250 19.5 64 156 8 313 4
Green tea 156 9.8 16 78 2 78 2
Thyme 625 9.8 64 156 4 156 4
Bearberry 313 2.4 128 1,000 0.25 1,000 0.25
Black seeds 500 62.5 8 1,000 0.5 2,000 0.25
Grape leaf extracts
Lasin 1,000 62.5 16 1,000 1 2,000 0.5
Merlot 1,000 62.5 16 1,000 1 2,000 0.5
Vranac 500 62.5 8 1,000 0.5 1,000 0.5
Babic´ 8,000 4,000 2 8,000 1 8,000 1
Debit 500 62.5 8 500 1 1,000 0.5
Zlatarica 1,000 31.3 32 500 2 500 2
Kujundzˇusˇa 4,000 62.5 64 2,000 2 2,000 2
Rkaciteli 4,000 62.5 64 2,000 2 2,000 2
Trnjak 2,000 500 4 500 4 1,000 2
Rudezˇusˇa 2,000 62.5 32 1,000 2 1,000 2
‘‘Fold diff’’ depicts fold difference, which is calculated using the formula: MIC of 11168/MIC of a mutant strain. $4-fold changes are indicated in bold.
*The MICs of 11168B are significantly lower than those of 11168 with phenolic compounds (P,0.05), rosemary extracts (P,0.01), herb extracts (P,0.01), and grape leaf
extracts (P,0.01).
doi:10.1371/journal.pone.0051800.t003
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Table 4. Susceptibilities of C. jejuni 11168 and its efflux mutants to phenolic compounds in the absence and presence of PAbN
(20 mg/mL)a, NMP (100 mg/mL)a, verapamil (100 mg/mL), reserpine (100 mg/mL) or CCCP (0.25 mg/mL)b.
Phenolic acid or
compound ±inhibitor 11168 11168B 11168F 11168R
MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff.
EGCG 78 78 78 313
+PAbN 9.8 8 19.5 4 19.5 4 9.8 32
+NMP 78 1 19.5 4 19.5 4 9.8 256
+Verapamil 78 1 78.5 1 78 1 78 4
+Reserpine 78 1 78.5 1 78 1 78 4
+CCCP 19.5 4 156 0.5 9.8 8 19.5 16
Rosmarinic 156 1.2 313 313
+PAbN 39 4 0.3 4 156 2 78 4
+NMP 39 4 1.2 1 78 4 156 2
+Verapamil 156 1 0.6 2 156 2 313 1
+Reserpine 156 1 0.6 2 78 4 313 1
+CCCP 19.5 8 0.6 2 39 8 156 2
Carnosic 19.5 19.5 39 78
+PAbN ,0.6 .32 0.3 64 2.4 16 ,0.6 .128
+NMP 4.9 4 2.4 8 39 1 39 2
+Verapamil 9.8 2 9.8 2 39 1 78 1
+Reserpine 9.8 2 19.5 1 39 1 78 1
+CCCP 4.9 4 19.5 1 39 1 78 1
Chlorogenic 313 4.9 313 313
+PAbN 2.4 128 0.3 16 313 1 39 8
+NMP 625 0.5 2.4 2 625 0.5 78 4
+Verapamil 625 0.5 9.8 0.5 313 1 313 1
+Reserpine 625 0.5 4.9 1 625 0.5 625 0.5
+CCCP 78 4 1.2 4 156 2 156 2
Gallic 313 4.9 78 78
+PAbN ,9.8 .32 0.3 16 19.5 4 ,9.8 .8
+NMP 19.5 16 0.3 16 39 2 39 2
+Verapamil 78 4 4.9 1 39 2 78 1
+Reserpine 156 2 4.9 1 39 2 78 1
+CCCP 78 4 ,0.3 .16 78 1 78 1
Sinapinic 313 78 156 156
+PAbN ,9.8 .32 ,1.2 .64 39 4 ,9.8 .16
+NMP ,9.8 .32 ,1.2 .64 78 2 156 1
+Verapamil 39 8 156 1 78 2 156 1
+Reserpine 19.5 16 78 1 78 2 156 1
+CCCP 78 4 ,1.2 .64 156 1 156 1
Vanillic 313 39 313 156
+PAbN ,0.6 .512 9.8 4 156 2 9.8 16
+NMP 4.9 64 2.4 16 156 2 78 2
+Verapamil 78 4 39 1 313 1 156 1
+Reserpine 156 2 19.5 2 313 1 156 1
+CCCP 156 2 19.5 2 313 1 156 1
Syringic 313 78 156 156
+PAbN 156 2 ,1.2 .64 19.5 8 ,9.8 .16
+NMP 156 2 ,1.2 .64 39 4 39 4
+Verapamil 313 1 39 2 78 2 156 1
+Reserpine 313 1 78 1 78 2 156 1
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statistically significant changes in the MICs and increased the
susceptibility of C. jejuni NCTC 11168 to all but two of the tested
compounds and extracts by 2-fold to 128-fold (Table 3), indicating
that the CmeABC efflux pump plays an important and broad role
in the resistance to phenolics. Notably, the MICs for rosmarinic,
chlorogenic and gallic acids decreased 64- to 128-fold in 11168B
compared with the wild-type strain, suggesting that CmeABC is
especially effective in the efflux of these phenolic compounds.
Similarly, significant increases in the susceptibilities in the cmeB
mutant strain were seen for all of the rosemary extracts (8- to 64-
fold), and for most of the herb (up to 128-fold) and vine-leaf (up to
64-fold) extracts. These data clearly indicate that these natural
pure phenolic compounds and extracts of plant phenolics
represent substrates for CmeABC in C. jejuni. Interestingly,
inactivation of the CmeB efflux-pump protein did not affect the
MICs of EGCG and carnosic acid (Table 3), suggesting that these
two compounds are not the substrates of CmeABC. Alternatively,
EGCG and carnosic acid may not enter into Campylobacter cells and
act on membrane or cell surfaces [31,32]. These two phenolics
have the lowest MICs, confirming them as the most efficient anti-
Campylobacter phenolics tested in this study.
In contrast to the results with 11168B, inactivation of the cmeF
gene had much smaller effects (up to 8-fold reduction or 4-fold
increase) on the MICs of these natural phenolic compounds
(Table 3). The MICs for the pure gallic, sinapinic, syringic and
ferulic acids and for most of the herb and vine-leaf extracts, were
reduced by 2- to 8-fold. Interestingly, the cmeF inactivation
increased the MICs of some of other compounds by 2- to 4-fold (e.
g. rosmarinic acid, carnosic acid, rosemary extracts V40 and I18,
bearberry, black seeds and grape leaf extract vranac) (Table 3).
The data obtained here indicate that CmeDEF plays a modest role
in modulating the resistance to different plant phenolic com-
pounds in C. jejuni.
It is known from previous studies that CmeABC contributes to
Campylobacter resistance to a broad spectrum of antimicrobial
agents and is the predominant efflux system in Campylobacter [20–
22], while CmeDEF plays a secondary role in conferring intrinsic
resistance to antimicrobials [26]. Findings from this study are
consistent with this notion as mutation of cmeB resulted in
significantly greater changes in the MICs (Table 3). To our
knowledge, this is the first study demonstrating that antibiotic
efflux pumps extrude phenolic acids, compounds or phenolic
extracts and contribute to the resistance of C. jejuni to these
compounds. It is of particular interest that each pure phenolic
compound or plant extract shows certain specificity for different
efflux pumps, suggesting that structural variations of the phenolic
compounds influence their interactions with the drug efflux
transporters in Campylobacter. Based on the MIC differences
observed with 11168 B and 11168F, we can conclude that
CmeABC is the predominant efflux pump in C. jejuni for the efflux
of pure phenolic compounds and phenolic extracts of plant origin.
CmeR functions as a transcriptional repressor that directly
interacts with the cmeABC promoter and modulates the expression
of cmeABC and mutation of cmeR will impede this repression,
leading to enhanced production of the CmeABC MDR efflux
pump [23]. As shown in Table 3, inactivation of cmeR indeed led to
slightly increased (up to 4-fold) or reduced (4-fold) resistance to
these natural phenolic compounds as reflected by the MIC
changes in comparison with the wild-type strain. Four of these
natural phenolic compounds (V70, peppermint, Babic´ and
chlorogenic acid) did not show a change in MIC in 11168R. This
cmeR inactivation resulted in a modest reduction in the MICs for
most of the tested compounds and extracts. On the contrary, it
increased the MICs of ECGC, rosmarinic and chlorogenic acid as
well as some rosemary and vine-leaf extracts by up to 4-fold
(Table 3). These results are consistent with a previous finding with
other antimicrobials that overexpression of CmeABC (mediated
by inactivating cmeR) only resulted in modest changes in drug
resistance [23]. The small MIC changes in 11168R are in contrast
to the significant MIC alterations in 11168B and suggest that the
function of CmeABC is already saturated by the base-level
expression and overexpression of this efflux pump does not further
enhance its function in the extrusion of phenolic compounds.
Alternatively, the modest changes of MICs in 11168R could be
explained by the fact that CmeR regulates multiple genes in C.
jejuni and inactivation of CmeR affects the expression (both down-
and up-regulation) of a number of genes [33], which collectively
might affect the impact of the cmeR mutation on the MICs.
The Effects of EPIs on the Resistance to Natural Phenolic
Compounds
In addition to using gene-specific mutants, we further examined
the role of efflux mechanisms in the resistance to natural phenolic
compounds using different EPIs including PAbN, NMP, verapa-
mil, reserpine, and CCCP. Two (PAbN and NMP) of these EPIs
have been evaluated to restore erythromycin susceptibility [24,34–
37] and influence the resistance to others antibiotics [30] in
Campylobacter spp., but none of them has been tested to modulate
Table 4. Cont.
Phenolic acid or
compound ±inhibitor 11168 11168B 11168F 11168R
MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff.
+CCCP 19.5 16 ,1.2 .64 9.8 16 156 1
Ferulic 313 78 156 156
+PAbN ,9.8 .32 ,1.2 .64 39 4 ,9.8 .16
+NMP 78 4 2.4 32 39 4 39 4
+Verapamil 156 2 78 1 313 0.5 156 1
+Reserpine 313 1 39 2 313 0.5 156 1
+CCCP 313 1 ,1.2 .64 ,9.8 .16 156 1
‘‘Fold diff.’’ indicates fold difference, which is calculated using the formula: MIC without an EPI/MIC with an EPI. $4-fold changes are indicated in bold.
aPAbN and NMP significantly (p,0.05) reduced the MICs of the phenolic compounds in 11168, 11168B, 11168F, and 11168R.
bCCCP significantly reduced the MICs of the phenolic compounds in 11168, 11168B and 11168F (p,0.05), but not in 11168R (p . 0.05).
doi:10.1371/journal.pone.0051800.t004
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the susceptibility of Campylobacter to phenolic acids or compounds
of plant phenolic extracts.
In the present study, we examined the susceptibility of C. jejuni
11168 and its mutant constructs to 9 pure phenolic compounds
and five phenolic extracts (four rosemary and vine-leaf extract) in
the absence and presence of each EPI. The MIC values are given
in Table 4 and Table 5. The resistance of C. jejuni 11168 to these
natural phenolic compounds was significantly reduced by PAbN
(from 2- to .512-fold MIC reductions), and the effects varied with
different compounds (Tables 4 and 5). NMP and CCCP also
produced variable but statistically significant decreases in the
MICs. On the other hand, verapamil and reserpine had little or no
effects on the MICs of these natural antimicrobials (Tables 4 and
5). These tested EPIs may have different modes of action in
Campylobacter, thus showing highly divergent effects on the MICs of
the tested phenolic compounds.
In 11168B, several EPIs increased its susceptibility to the pure
phenolic compounds and extracts of plant phenolics by up to.64-
fold. The MIC reduction was particularly obvious in the cases of
carnosic, sinapinic, syringic and ferulic acids (Tables 4, 5). Similar
to what was observed with the wild-type 11168, PAbN, NMP and
CCCP showed greater, potentiating effects than the other EPIs
(p,0.05). The fact that MICs in 11168B were further reduced by
EPIs strongly suggests that other efflux mechanisms also contribute
to Campylobacter resistance to natural phenolic compounds.
The EPIs were further evaluated in the cmeF mutant (11168F).
Again, the significant potentiating effects (MIC reduction) were
mainly seen with PAbN, NMP and CCCP, but the magnitudes of
MIC reduction were generally smaller in 11168F than in 11168B
and the wide-type strain, except for V70 and I18 rosemary, with
which PAbN produced a greater MIC reduction in 11168F than
in 11168B (Tables 4 and 5). In the cmeR mutant (11168R), PAbN
Table 5. Susceptibilities of C. jejuni 11168 and its efflux mutants to the selected plant extracts in the presence or absence of PAbN
(20 mg/mL)a, NMP (100 mg/mL) a, verapamil (100 mg/mL), reserpine (100 mg/mL) or CCCP (0.25mg/mL)b.
Extract ±inhibitor 11168 11168B 11168F 11168R
MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff. MIC (mg/mL) Fold diff.
I18 313 19.5 625 156
+PAbN ,0.6 .512 19.5 1 39 16 39 4
+NMP 19.5 16 39 0.5 313 2 19.5 8
+Verapamil 39 8 19.5 1 625 1 156 1
+Reserpine 19.5 16 4.9 4 625 1 156 1
+CCCP 4.9 64 9.8 2 313 2 156 1
V40 78 9.8 156 156
+PAbN 4.9 16 ,0.3 $32 9.8 16 9.8 16
+NMP 19.5 4 ,4.9 $2 78 2 78 2
+Verapamil 39 2 04.9 2 156 1 156 1
+Reserpine 39 2 9.8 1 78 2 78 2
+CCCP 4.9 16 9.8 1 78 2 156 1
V70 78 4.5 78 78
+PAbN 19.5 4 9.8 0.5 ,1.2 $64 78 1
+NMP 39 2 9.8 0.5 19.5 2 39 2
+Verapamil 78 1 9.8 0.5 78 1 156 0.5
+Reserpine 78 1 9.8 0.5 78 1 156 0.5
+CCCP 39 2 4.5 1 39 2 78 1
A40 156 2.4 156 313
+PAbN 39 4 0.3 8 78 2 39 8
+NMP 78 2 0.3 8 39 4 39 8
+Verapamil 156 1 1.2 2 313 0.5 313 1
+Reserpine 156 1 2.4 1 313 0.5 313 1
+CCCP 39 4 2.4 1 156 1 313 1
Babic´ 8,000 4,000 8,000 8,000
+PAbN 2,000 4 250 16 500 8 500 8
+NMP 1,000 8 1,000 4 2,000 2 2,000 2
+Verapamil 8,000 1 2,000 2 4,000 1 2,000 2
+Reserpine 8,000 1 4,000 1 4,000 1 2,000 2
+CCCP 125 64 125 32 125 32 125 32
‘‘Fold diff.’’ indicates fold difference, which is calculated using the formula: MIC without an EPI/MIC with an EPI. $4-fold changes are indicated in bold.
aPAbN and NMP significantly (p,0.05) reduced the MICs of the plant extracts in 11168, 11168F and 11168R, but not in 11168B (p . 0.05).
bThe effect of CCCP on the MICs of the plant extracts was only significant with 11168 (p,0.05).
doi:10.1371/journal.pone.0051800.t005
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significantly reduced the MICs for all of the pure phenolic
compounds (with up to .128-fold MIC reductions), and for all of
the extracts tested except V70. Interestingly, NMP produced a
256-fold reduction in the MIC of EGCG in 11168R, but had no
or limited potentiating activity on EGCG in the wild-type and
other mutant strains. This suggests that inactivation of CmeR
might alter a mechanism in C. jejuni, which makes the organism
significantly more susceptible to EGCG inhibition in the presence
of NMP. For all of the tested pure phenolic compounds and plant
extracts in the wild type and mutant strains (Tables 4 and 5),
PAbN showed the most effective potentiating effects, followed by
CCCP, NMP, reserpine and verapamil. Results from the EPI
experiments further indicate the complexity of mechanisms that
influence the susceptibility of C. jejuni to plant phenolic
compounds.
This study represents a comprehensive evaluation of the anti-
Campylobacter activities of natural phenolic compounds and
extracts. All of the tested phenolics showed activities against
Campylobacter spp. isolates from different sources, although their
activities were variable and closely related to their compositions.
Additionally, the tested natural phenolic compounds and plant
extracts showed similar activities against both C. jejuni and C. coli as
well as antibiotic resistant Campylobacter, suggesting that they may
be potentially used as alternative antimicrobials for the control of
sensitive and multidrug-resistant Campylobacter. Although practical
use of these plant compounds requires further research and
development, it is possible that they can be developed for use in
live birds or processed meat to reduce Campylobacter colonization
and contamination. Poultry are a major reservoir for Campylobacter
and contaminated poultry meat serves as a major vehicle for
foodborne transmission of Campylobacter humans [1]. Due to the
rising prevalence of antibiotic resistance, alternatives to traditional
antibiotics are needed to control Campylobacter in animal reservoirs.
One potential use of these plant compounds could be incorporated
into feed or water to reduce the colonization and prevalence of
Campylobacter in birds at the preharvest stage. Additionally, the
natural plant antimicrobials may be used as additives, preservation
or decontamination treatments to reduce Campylobacter contami-
nation on chicken carcasses during the post-harvest stage.
To facilitate the practical use of these phenolics, it is important
to understand the factors in C. jejuni that affect the susceptibility to
the antimicrobials. Using gene-specific knockout mutants and
EPIs, we demonstrated that complex efflux mechanisms are
involved in the resistance of C. jejuni to phenolic compounds and
extracts of plant phenolics (Tables 3, 4 and 5). Particularly, the
CmeABC efflux pump is a significant player in reducing the
susceptibility to the phenolics, while CmeDEF plays a modest role
in the resistance. Additionally, our results suggest that non-
CmeABC and non-CmeDEF efflux systems also contribute to
Campylobacter resistance to phenolic compounds. Collectively, these
findings represent the first comprehensive evaluation of the anti-
Campylobacter activities of plant phenolic compounds and suggest
that these compounds can be further developed as alternative
antimicrobials to control Campylobacter contamination in food
production and processing, or as therapeutics for clinical treatment
of campylobacteriosis. These possibilities await investigations in
future studies.
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